How much does Ozempic cost? With and without insurance

Ozempic monthly cost breakdown

The honest answer runs from $25 a month to nearly $1,000 — and the deciding variable isn’t which pharmacy you use, it’s your diagnosis. Figures below are drafts pending verification; always confirm current pricing before budgeting.

Why the diagnosis matters so much: Ozempic is FDA-approved for type 2 diabetes, so that’s what insurers agree to pay for. The enormous off-label weight-loss market runs largely on cash — which is exactly the gap the rest of this page maps.

Ozempic cost without insurance

Walk into a pharmacy with no coverage and the list price is about $998 for a month’s supply — one pen, four maintenance doses. Almost nobody should actually pay that, because Novo Nordisk now sells around the pharmacy counter entirely.

NovoCare Pharmacy is Novo’s direct-to-patient program: a cash price of about $499 a month, shipped to your door, no insurance involved (⚠ verify current terms). You still need a valid prescription — this is a payment channel, not a prescribing one — but it roughly halves the sticker for anyone paying out of pocket, including people whose plans deny weight-loss use.

The annual math is worth staring at, because this is a long-term medication: roughly $12,000 a year at list versus about $6,000 through NovoCare (⚠ verify). That gap is also why the coverage question below matters more than any coupon.

Below the $499 price, be suspicious. Discount cards shave modest amounts off retail, and anything dramatically cheaper that claims to be brand Ozempic probably isn’t.

Ozempic cost with insurance

For type 2 diabetes, coverage is the norm: most commercial plans and Medicare Part D include Ozempic, often behind a prior authorization confirming the diagnosis. What you pay depends on your plan’s tier — copays span roughly $25 to the full $998 — and commercially insured patients can usually stack the savings card to pull it down to $25.

For weight loss without a diabetes diagnosis, the plain truth: coverage is usually denied. Insurers check the diagnosis code, and “off-label for weight” is one of the most reliably rejected claims in the formulary. If weight is the goal, the more honest path is usually pursuing Wegovy — same molecule, an actual weight-management label insurers can say yes to — or comparing the cheapest legitimate GLP-1 routes.

Does Medicare cover Ozempic?

For type 2 diabetes, yes — most Part D plans cover it, subject to the plan’s formulary and prior authorization, and the Part D redesign now caps annual out-of-pocket drug costs (⚠ verify current cap figure). For weight loss, no: Part D has long been barred from covering weight-loss drugs (⚠ policy in flux — verify before launch), so the diagnosis distinction is even sharper than with commercial insurance.

One more Medicare wrinkle: the $25 savings card can’t be used with any government insurance. Medicare patients who get denied are looking at the ~$499 NovoCare cash price, not the card.

How to pay less for Ozempic

Three legitimate levers, in the order to try them.

The savings card, fine print included

As low as $25 per 1–3 month supply — but only if you have commercial insurance that covers Ozempic. Government insurance disqualifies you, paying fully in cash disqualifies you, and there are supply limits, annual savings caps, and an expiration date on the offer (⚠ verify current terms). It’s a copay card, not a discount card: it lowers what you owe on a covered claim, it doesn’t create coverage.

NovoCare Pharmacy self-pay

The ~$499 direct price is the floor for legitimate brand Ozempic without coverage. No eligibility maze — it’s for exactly the people the savings card excludes.

Is there a generic Ozempic?

No. There is no generic semaglutide in the US — the patents run years into the future (⚠ verify timeline) — so anyone selling “generic Ozempic” is, by definition, selling something that isn’t an FDA-approved product. That includes the sub-$300 telehealth offers: compounded semaglutide is not a generic, it’s a pharmacy-mixed copy in a legal grey zone since the FDA declared the shortage over. We cover that landscape in the semaglutide guide, informationally — but don’t let anyone sell it to you as “generic.”